<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Babesiosis: Microbiology, epidemiology, and pathogenesis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Babesiosis: Microbiology, epidemiology, and pathogenesis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Babesiosis: Microbiology, epidemiology, and pathogenesis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Peter J Krause, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Edouard G Vannier, PhD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Johanna Daily, MD, MSc</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elinor L Baron, MD, DTMH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jun 22, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Babesiosis is an infectious disease caused by protozoa of the genus <em>Babesia</em> and is transmitted primarily by tick vectors. Transmission rarely occurs through blood transfusion, solid organ transplantation, or congenitally. <em>Babesia</em> protozoa infect mammals and cause lysis of host red blood cells [<a href="#rid1">1-4</a>].</p><p>The microbiology, epidemiology, and pathogenesis of babesiosis will be reviewed here. The clinical manifestations, diagnosis, treatment, and prevention of babesiosis are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5670.html" rel="external">"Babesiosis: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/113483.html" rel="external">"Babesiosis: Treatment and prevention"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">MICROBIOLOGY</span><span class="headingEndMark"> — </span><em>Babesia</em> species have been classified into four clades [<a href="#rid5">5-7</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Clade 1 contains <em>Babesia microti</em> organisms that cause human babesiosis, primarily in the United States. Cases also have been reported in Europe, Asia, and Australia. Initially considered as a single species, <em>B. microti</em> appears to be genetically diverse [<a href="#rid7">7</a>]. In fact, <em>B. microti</em> may be a genus on its own that ranks equally to the <em>Babesia</em> sensu stricto genus (clades 3 and 4, see below) [<a href="#rid8">8</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Clade 2 contains <em>Babesia duncani</em> (WA1, WA2, CA5, CA6) and <em>B. duncani-</em>related organisms (CA1, CA3, CA4), the main etiologic agents of human babesiosis along the West coast of the United States.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Clade 3 contains <em>Babesia divergens</em> isolates from cattle in Europe, <em>B. divergens</em>-like organisms identified in humans in Europe and the United States, and <em>Babesia venatorum</em>, identified in humans in Europe and mainland China.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Clade 4 contains <em>Babesia</em> species that can infect humans but usually are found in domesticated vertebrates. These include <em>Babesia crassa-</em>like organism and <em>Babesia</em> <em>motasi</em>-like organism, which typically infect sheep and goats [<a href="#rid9">9,10</a>].</p><p></p><p>The phylogenetic classification is generally consistent with classifications based on morphology and life cycle characteristics [<a href="#rid3">3,5,11,12</a>]. Trophozoites of <em>Babesia</em> in clades 1 and 2 are small in diameter (&lt;3 microns) and form up to four merozoites arranged in a tetrad ("Maltese cross"). Transmission of <em>Babesia</em> in clades 1 and 2 is transstadial (eg, from larvae to nymphs and from nymphs to adults) but not transovarial (from adults to eggs), indicating that vertebrate hosts are an absolute requirement for their maintenance in the tick life cycle.</p><p>Trophozoites of <em>Babesia </em>in clades 3 and 4 typically are large in diameter (&gt;3 microns) and form only two merozoites. Exceptions to these phenotypes within clade 3 include <em>Babesia</em> that infect humans, such as <em>B. divergens</em>, <em>B. divergens</em>-like organisms, and <em>B. venatorum</em>. In human red blood cells (RBCs), their trophozoites are small in diameter (&lt;3 microns) and their merozoites can be arranged in tetrads [<a href="#rid12">12-14</a>]. Transmission of <em>Babesia</em> in clades 3 and 4 is both transovarial and transstadial, suggesting that vertebrate hosts are not essential for their short-term maintenance in the tick life cycle. These organisms are referred to as "true"<em> Babesia</em> species or as<em> Babesia</em> species "sensu stricto".</p><p>Both <em>Babesia</em> and <em>Plasmodium</em> parasites invade RBCs. They differ in that <em>Plasmodium</em> species are transmitted by mosquitoes from person to person, thereby using humans as reservoir hosts, have an exoerythrocytic (hepatic) stage, and leave hemozoin deposits in RBCs. In contrast, <em>Babesia</em> species are transmitted by ticks, are not transmitted from person to person but rather use mammals as reservoir hosts, lack an exoerythrocytic stage, and do not leave hemozoin deposits in RBCs [<a href="#rid3">3,5,11,12</a>].</p><p class="headingAnchor" id="H8"><span class="h1">EPIDEMIOLOGY</span></p><p class="headingAnchor" id="H1027446656"><span class="h2">United States</span></p><p class="headingAnchor" id="H9"><span class="h3">Babesia microti</span><span class="headingEndMark"> — </span><em>B. microti</em> is the predominant etiologic agent of babesiosis in the United States [<a href="#rid3">3</a>]. White-footed mice (<em>Peromyscus leucopus</em>) have long been considered the primary reservoir host for <em>B. microti</em> but other small mammals, such as shrews and chipmunks, are competent reservoirs [<a href="#rid15">15,16</a>]. The primary vector for transmission of <em>B. microti</em> to humans is the nymphal stage of the <em>Ixodes scapularis</em> (<a class="graphic graphic_figure graphicRef68309" href="/z/d/graphic/68309.html" rel="external">figure 1</a> and <a class="graphic graphic_figure graphicRef65153" href="/z/d/graphic/65153.html" rel="external">figure 2</a>).</p><p class="headingAnchor" id="H10"><span class="h4">Geography</span><span class="headingEndMark"> — </span>Most cases of babesiosis (&gt;98 percent) occur in ten states: eight in the Northeast (Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Rhode Island and Vermont) and two in the upper Midwest (Minnesota and Wisconsin) (<a class="graphic graphic_figure graphicRef113492" href="/z/d/graphic/113492.html" rel="external">figure 3</a>) [<a href="#rid17">17-20</a>].</p><p>The states with the highest annual incidence between 2011-2019 were Rhode Island, Connecticut, and Massachusetts (13.4, 6.8, and 6.7 cases per 100,000 residents, respectively). The states with the highest number of cases during this same period were New York, Massachusetts, and Connecticut (4738, 4136, and 2200, respectively).</p><p class="headingAnchor" id="H11"><span class="h4">Incidence and prevalence</span><span class="headingEndMark"> — </span>The incidence of babesiosis has increased considerably in the Northeast over the past three decades [<a href="#rid21">21</a>]. Babesiosis has been a nationally notifiable disease since January 2011. In 2019, babesiosis was a reportable condition in 40 states and the District of Columbia, and at least one case was reported in 25 of these states to the United States Centers for Disease Control and Prevention. The number of annual cases increased between 2011 and 2019 from 1126 to 2418 cases [<a href="#rid20">20,22</a>]. Babesiosis is expected to remain an emerging infectious disease for many years to come. </p><p>The increase in incidence has been attributed to several factors including expanding deer population with concomitant increased tick density, increased human habitat in wooded areas, and heightened community awareness. Deer numbers have increased due to reforestation, lack of predators, and insufficient culling of the herd.</p><p>Seroprevalence varies by location, year, time of year, and population surveyed (<a class="graphic graphic_table graphicRef64802" href="/z/d/graphic/64802.html" rel="external">table 1</a>). In the Northeast and the upper Midwest, <em>B. microti</em> seroprevalence in healthy blood donors has ranged from 0.5 to 16.0 percent. The discrepancy between seroprevalence and the prevalence of clinical disease suggests that asymptomatic and self-limited infection is common [<a href="#rid23">23</a>]. A carefully designed epidemiologic study found that about 20 percent of adults and 40 percent of children experience asymptomatic infection [<a href="#rid24">24</a>]. (See  <a class="medical medical_review" href="/z/d/html/5670.html" rel="external">"Babesiosis: Clinical manifestations and diagnosis", section on 'Asymptomatic infection'</a>.)</p><p>The prevalence of <em>B. microti</em> infection in nymphal <em>I. scapularis </em>ticks ranges from 1 percent (in newly endemic areas) to 20 percent (in some well-established areas) [<a href="#rid25">25</a>].</p><p class="headingAnchor" id="H12"><span class="h4">Transmission</span><span class="headingEndMark"> — </span><em>B. microti</em> is transmitted primarily by ticks and rarely by blood transfusion, solid organ transplantation, or transplacentally.</p><p class="headingAnchor" id="H2836481655"><span class="h5">Tick bite</span><span class="headingEndMark"> — </span>Most infections with <em>B. microti </em>are acquired through tick bite between May and September; more than three-fourths of cases are diagnosed from June through August [<a href="#rid17">17,22,26,27</a>]. The nymphal tick is the primary vector for transmission of infection, although adult ticks also transmit <em>B. microti</em> [<a href="#rid3">3,11</a>].</p><p>The life cycle of <em>I. scapularis</em> spans over two years and includes deer and small mammals, especially white-footed mice (<a class="graphic graphic_figure graphicRef65153" href="/z/d/graphic/65153.html" rel="external">figure 2</a> and <a class="graphic graphic_figure graphicRef113598" href="/z/d/graphic/113598.html" rel="external">figure 4</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Adult female ticks lay eggs in the spring (year 1). <em>B. microti</em> infection is not transmitted from adult ticks to eggs.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tick eggs hatch and larvae appear in late July (year 1).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tick larvae feed on white-footed mice (<em>P. leucopus</em>, a primary reservoir for <em>B. microti</em>) in late summer (year 1). Red blood cells (RBCs) from infected mice (or other vertebrate hosts) accumulate in the mid-gut of the tick larva where <em>Babesia</em> gametocytes mature into gametes. Sexual reproduction involves fusion of one gamete with another. The resulting zygote invades the gut epithelium and becomes an ookinete. Ookinetes reach the hemolymph and migrate to the tick salivary glands where they hypertrophy into sporoblasts. Sporoblasts remain dormant while the larva overwinters.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tick larvae molt into nymphs in the spring (year 2). <em>B. microti </em>is transmitted from larvae to nymphs (transstadial transmission).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tick nymphs, the primary vector for <em>B. microti</em> transmission, feed on small mammals in early summer (year 2). They also feed on humans, but humans are dead-end hosts. Sporozoites are delivered to the host dermis 36 to 72 hours after nymphal attachment; therefore, tick removal during the first 24 hours of attachment eliminates the risk of transmission. Sporozoites migrate to the bloodstream where they invade erythrocytes and undergo asexual replication to yield merozoites. Merozoites are released into the bloodstream and invade nearby erythrocytes. (See  <a class="medical medical_review" href="/z/d/html/5670.html" rel="external">"Babesiosis: Clinical manifestations and diagnosis", section on 'Microscopy'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tick nymphs molt into adults in the fall (year 2).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Adult ticks feed on white-tailed deer (<em>Odocoileus virginianus</em>) in the fall (year 1). Deer are not competent reservoirs for <em>B. microti</em> but are critical for expansion of the tick population because adult ticks mate on deer, and female ticks take a blood meal on deer which provides sufficient protein to lay eggs in the spring. Adult ticks occasionally feed on humans.</p><p></p><p class="headingAnchor" id="H523750851"><span class="h5">Transfusion of blood products</span><span class="headingEndMark"> — </span>Babesiosis may be transmitted by transfusion of blood products from asymptomatic donors. Most cases of transfusion-transmitted babesiosis occur from June through November (consistent with the seasonality of tick-acquired babesiosis) [<a href="#rid28">28,29</a>]. Transfusion-transmitted babesiosis may occur at any time of year, however, because asymptomatic infection can persist for more than a year and because the incubation period after blood transfusion can be as long as six months. Transfusion-transmitted babesiosis usually is reported from endemic areas but can occur outside of endemic areas when donors residing in nonendemic areas become infected while traveling in endemic areas or when contaminated blood products donated in endemic areas are exported to nonendemic areas [<a href="#rid28">28</a>]. (See  <a class="medical medical_review" href="/z/d/html/7946.html" rel="external">"Blood donor screening: Laboratory testing", section on 'Babesia microti'</a>.)</p><p>More than 250 cases of transfusion-transmitted babesiosis have been reported [<a href="#rid2">2,28,30,31</a>]. The largest series of transfusion-transmitted babesiosis included 159 patients; the median age was 65 years, two-thirds of patients were &gt;50 years, and 10 percent were neonates [<a href="#rid28">28</a>]. Approximately 20 percent of these cases were fatal. </p><p>Transfusion-transmitted babesiosis often is severe because recipients of blood products are often immunocompromised or have coexisting medical conditions. The most frequent conditions or procedures associated with transfusion-transmitted babesiosis include hematologic disorders, cardiovascular surgery or procedures, gastrointestinal bleeding or surgery, and complications of prematurity in the newborn. Transfusion-transmitted babesiosis also has occurred in patients who have undergone post-traumatic splenectomy or organ transplantation [<a href="#rid28">28</a>].</p><p>Most cases of transfusion-transmitted babesiosis have involved packed RBCs. A small number of cases have been attributed to whole blood-derived platelets [<a href="#rid28">28</a>]. Typically, liquid-stored RBCs are involved; frozen deglycerolized RBCs are seldom implicated. The median age of liquid-stored RBCs at time of transfusion has ranged from 4 to 42 days [<a href="#rid32">32-35</a>].</p><p>In May 2019, the US Food and Drug Administration recommended blood donor screening for <em>B. microti</em> with a licensed nucleic acid test in 14 states (Connecticut, Delaware, Maine, Maryland, Massachusetts, Minnesota, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, Vermont, Virginia, Wisconsin) and Washington, DC [<a href="#rid33">33</a>]. Licensed nucleic acid tests use transcription-mediated amplification technology; their 95 percent limit of detection ranges from 1.8 to 3.1 parasites per mL of blood [<a href="#rid36">36,37</a>]. In the year following implementation of the FDA recommendation by the American Red Cross (ARC), no cases of transfusion-transmitted babesiosis were reported to the ARC [<a href="#rid31">31,38</a>]. (See  <a class="medical medical_review" href="/z/d/html/7946.html" rel="external">"Blood donor screening: Laboratory testing", section on 'Babesia microti'</a>.) </p><p>Issues related to blood donor evaluation are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/7946.html" rel="external">"Blood donor screening: Laboratory testing", section on 'Babesia microti'</a>.)</p><p class="headingAnchor" id="H3947550692"><span class="h5">Solid organ transplantation</span><span class="headingEndMark"> — </span>Transmission of <em>B. microti</em> infection by solid organ transplantation has been described in two renal transplant recipients from an organ donor who received multiple transfusions on the day he died from traumatic injuries [<a href="#rid39">39</a>].</p><p class="headingAnchor" id="H3340562481"><span class="h5">Transplacental transmission</span><span class="headingEndMark"> — </span>More than 10 cases of congenital infection with <em>B. microti</em> have been reported in the United States [<a href="#rid40">40-48</a>]. In all but two cases, infants were born at term and symptoms developed between the third and sixth week of age [<a href="#rid40">40,45-47</a>]. There was no history of tick bites for the neonates. In three cases, the mother recalled being bitten by a tick one to seven weeks prior to delivery. At the time of diagnosis, parasitemia typically ranged from 2 to 5 percent in the infants. Parasite DNA was amplified in the serum from two mothers and in the placental tissue from another. All infants and mothers had antibodies against <em>B. microti</em> antigen.</p><p>One case of congenital babesiosis provided definitive proof that <em>B. microti</em> can be transmitted vertically [<a href="#rid41">41</a>]. The mother was hospitalized at week 30 of gestation with a 10-day history of fever and rigors. Intraerythrocytic ring forms were noted in 9 percent of the mother's RBCs but also in the amniotic fluid that had been obtained without traversing the placenta. The mother delivered by emergency cesarean section due to fetal distress. Immediately following delivery, intraerythrocytic parasites were observed on smears of blood obtained from the neonate.</p><p>Management of (suspected) congenital babesiosis has consisted of <a class="drug drug_general" data-topicid="8957" href="/z/d/drug information/8957.html" rel="external">atovaquone</a> (40 mg/kg/day orally divided in two doses) plus oral <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">azithromycin</a> (10 or 12 mg/kg/day orally) for up to 10 days. Persistent anemia has been addressed by transfusion of packed RBCs.</p><p class="headingAnchor" id="H13"><span class="h4">Risk factors</span><span class="headingEndMark"> — </span>Risk factors for babesiosis include residence in or travel to an endemic area within the previous six weeks or blood transfusion within the previous six months.</p><p>Risk factors for severe babesiosis include [<a href="#rid26">26,27,49-51</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Asplenia or hyposplenism – Many fatal cases of babesiosis occur in asplenic individuals, although asplenia does not always result in severe disease.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Immunosuppression caused by:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>HIV/AIDS with a low CD4 cell count</p><p class="bulletIndent2"><span class="glyph">•</span>Malignancy and/or cancer chemotherapy</p><p class="bulletIndent2"><span class="glyph">•</span>Immunosuppressive therapy for solid organ or stem cell transplantation</p><p class="bulletIndent2"><span class="glyph">•</span>Blockade of tumor necrosis factor-alpha (<a class="drug drug_general" data-topicid="8925" href="/z/d/drug information/8925.html" rel="external">etanercept</a>, <a class="drug drug_general" data-topicid="8984" href="/z/d/drug information/8984.html" rel="external">infliximab</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Depletion of mature B cells by anti-CD20 antibody (<a class="drug drug_general" data-topicid="9616" href="/z/d/drug information/9616.html" rel="external">rituximab</a>, <a class="drug drug_general" data-topicid="112485" href="/z/d/drug information/112485.html" rel="external">ocrelizumab</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Age – Most cases of severe babesiosis in otherwise healthy patients occur among individuals &gt;50 years. Neonates are also at risk for severe disease.</p><p></p><p>Risk factors for relapsing babesiosis (despite a standard course of antimicrobial therapy) include malignancy (especially B cell lymphoma) or other conditions treated with <a class="drug drug_general" data-topicid="9616" href="/z/d/drug information/9616.html" rel="external">rituximab</a>, malignancy together with asplenia, solid organ or stem cell transplantation, and HIV/AIDS.</p><p class="headingAnchor" id="H1911425128"><span class="h4">Coinfection with other tick-borne illnesses</span><span class="headingEndMark"> — </span>Other pathogens transmitted by <em>I. scapularis</em> ticks include <em>Borrelia burgdorferi</em>, <em>Anaplasma phagocytophilum</em>, <em>Borrelia miyamotoi</em>, <em>Borrelia mayonii</em>, Powassan virus, and <em>Ehrlichia muris</em>-like agent. (See  <a class="medical medical_review" href="/z/d/html/7914.html" rel="external">"Diagnosis of Lyme disease"</a> and  <a class="medical medical_review" href="/z/d/html/7907.html" rel="external">"Human ehrlichiosis and anaplasmosis"</a> and  <a class="medical medical_review" href="/z/d/html/101368.html" rel="external">"Borrelia miyamotoi infection"</a> and  <a class="medical medical_review" href="/z/d/html/1293.html" rel="external">"Arthropod-borne encephalitides", section on 'Powassan virus'</a>.)</p><p>In babesiosis and Lyme disease endemic areas, about half (range 23 to 72 percent) of babesiosis patients experience Lyme disease coinfection, whereas about a tenth (2 to 40 percent) of Lyme disease patients experience concurrent babesiosis [<a href="#rid1">1,25,52,53</a>]<em>.</em></p><p class="headingAnchor" id="H14"><span class="h3">Other Babesia species</span><span class="headingEndMark"> — </span>Uncommon Babesia species that cause human babesiosis in the United States include <em>B. duncani </em>and<em> B. divergens</em>:</p><p class="bulletIndent1"><span class="glyph">●</span><em>B. duncani</em> and related organisms – <em>B. duncani</em> is closely related to <em>Babesia conradae</em> (a <em>Babesia</em> species of domesticated dogs in California) and to a <em>Babesia</em> species of wildlife mammals in the western United States [<a href="#rid5">5</a>]. The tick vector for <em>B. duncani</em> is thought to be <em>Dermacentor albipictus </em>[<a href="#rid54">54</a>].<em> B. duncani</em> has caused sporadic disease along the West coast. Two cases of babesiosis due to <em>B. duncani</em> and related organisms have been described in Washington state, one case in Oregon, and six cases have been described in California [<a href="#rid54">54-58</a>]. Of these, five cases were attributed to tick bites and occurred in men ≤50 years; four of the five patients were asplenic [<a href="#rid56">56,58</a>]. The other three cases were acquired through blood transfusion [<a href="#rid55">55,57,59</a>]. The blood donors either had no symptoms or experienced mild symptoms (nausea, fatigue) prior to donation [<a href="#rid55">55,57,59</a>]. The incidence of <em>B. duncani</em> infection is uncertain [<a href="#rid55">55,56,58</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>B. divergens</em>-like organisms – Babesiosis due to <em>B. divergens</em>–like organisms was first described in a Missouri man [<a href="#rid60">60</a>]; subsequent cases were reported from Kentucky, Washington state, and Michigan [<a href="#rid61">61,62</a>]. A case of possible transfusion-transmitted infection has been reported from Arkansas [<a href="#rid63">63</a>]. All patients were asplenic and ≥50 years of age. The incidence of infection with <em>B. divergens</em>-like organisms is unknown but is likely to be low. In five cases, the causative organisms were identical to organisms obtained from eastern cottontail rabbits on Nantucket Island, Massachusetts [<a href="#rid13">13</a>]. The tick vector is thought to be <em>Ixodes dentatus</em> but has not been identified conclusively [<a href="#rid3">3</a>].</p><p></p><p class="headingAnchor" id="H15"><span class="h2">Europe</span><span class="headingEndMark"> — </span>Cases of babesiosis in Europe have been reported sporadically.</p><p class="headingAnchor" id="H906578378"><span class="h3">B. divergens</span><span class="headingEndMark"> — </span>The most common cause of babesiosis in Europe is <em>B. divergens</em>. Cattle are the main vertebrate host for <em>B. divergens</em>. About 40 cases of babesiosis in Europe have been attributed to <em>B. divergens</em>, mostly in France and Ireland, particularly in regions with cattle [<a href="#rid12">12</a>]. Individuals at risk include farmers, veterinarians, foresters, and vacationers engaged in outdoor activities. Isolated cases have been reported from Finland, Norway, Sweden, Poland, Spain, Portugal, and Croatia. The majority of cases occurred in asplenic individuals who became ill between May and September. Nearly all cases have been attributed to bites of the <em>Ixodes ricinus</em> tick; both nymphs and adult ticks are vectors.</p><p>Serosurveys have demonstrated 0.8 to 2.1 percent seroprevalence of <em>B. divergens</em> among healthy blood donors in Europe [<a href="#rid12">12,63-65</a>]. Among patients with clinical Lyme borreliosis or serological evidence of <em>B. burgdorferi </em>sensu lato<em> </em>infection, seroprevalence has ranged from 4 to 13 percent [<a href="#rid64">64,66</a>].</p><p class="headingAnchor" id="H17"><span class="h3">B. microti</span><span class="headingEndMark"> — </span>The first autochthonous case of babesiosis due to <em>B. microti</em> was described in Germany and occurred in a 42-year-old woman who was receiving chemotherapy for acute myeloid leukemia and had received numerous platelet concentrates [<a href="#rid67">67</a>]. The incriminated unit was transfused six days prior to diagnosis of babesiosis and had been prepared from a blood donation by an individual who subsequently tested seropositive for <em>B. microti</em>. Additional autochthonous cases have been reported from northeastern Poland.</p><p>Most cases of babesiosis due to <em>B. microti</em> have occurred in travelers upon return to their home country (Austria, the Czech Republic, Denmark, France, and the Netherlands) from the northeastern United States. Asymptomatic infection has been described in Poland; <em>B. microti</em> most likely was acquired locally because the carriers were forestry workers [<a href="#rid68">68</a>].</p><p><em>B. microti</em> infections may be under-recognized in Europe. Serosurveys have demonstrated a seroprevalence of 1.5 to 3.4 percent among healthy individuals in regions where <em>I. ricinus</em> ticks are endemic [<a href="#rid64">64,69,70</a>]. Among patients who had a history of tick bite and presented with fever and fatigue, 9 percent were seropositive for <em>B. microti</em> antibody [<a href="#rid71">71</a>]. Among patients with clinical evidence of Lyme borreliosis or serological evidence of <em>B. burgdorferi</em> sensu lato infection, seroprevalence was 11.5 percent [<a href="#rid64">64</a>].</p><p class="headingAnchor" id="H18"><span class="h3">B. venatorum</span><span class="headingEndMark"> — </span><em>B. venatorum</em> is closely related to <em>Babesia odocoilei</em>, a <em>Babesia</em> species of white-tailed deer in the United States [<a href="#rid72">72</a>]. In Europe, mammalian reservoirs include roe deer, and the tick vector is <em>I. ricinus</em> [<a href="#rid73">73</a>]. Five cases of babesiosis due to <em>B. venatorum</em> have been reported [<a href="#rid14">14,72,74,75</a>]. All patients were men ≥50 years and had undergone splenectomy because of Hodgkin's disease or hairy cell leukemia.</p><p>Sera from patients infected with <em>B. venatorum</em> cross-react with <em>B. divergens</em> antigen, raising the possibility that some of the cases attributed to <em>B. divergens</em> on the basis of serology were caused by <em>B. venatorum</em> [<a href="#rid72">72</a>]. In the absence of an immunofluorescence antibody test specific for <em>B. venatorum</em>, the incidence of infection with <em>B. venatorum</em> remains unknown.</p><p class="headingAnchor" id="H829333523"><span class="h3">B. crassa-like organism</span><span class="headingEndMark"> — </span><em>B. crassa</em>-like organisms have caused disease in one patient in Slovenia and another in western France. <em>B. crassa</em> is a parasite of goats and sheep. The vector for transmission to humans is unknown but may be <em>Haemaphysalis concinna</em>. </p><p class="headingAnchor" id="H4264239666"><span class="h2">Asia</span><span class="headingEndMark"> — </span>Babesiosis is increasingly reported from Asia, especially mainland China where <em>B. venatorum</em>, <em>B. microti,</em> and, <em>B. crassa</em>-like organism have been identified as human pathogens [<a href="#rid10">10,76-81</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><em>B. venatorum</em> – <em>B. venatorum </em>is endemic in northeastern China<em>.</em> Isolates obtained from these patients are identical to those from Europe. The animal reservoir is unknown; the tick vector most likely is <em>Ixodes persulcatus</em> [<a href="#rid76">76</a>]. A single case was reported from northwestern China.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>B. microti</em> – <em>B. microti </em>infection is found in southwestern China and in the Heilongjiang province in northeastern China [<a href="#rid77">77,78,80,81</a>]. Cases have been sporadically reported in Taiwan and Japan. The single case reported from Japan was caused by a Kobe-type organism; the vertebrate reservoir was the field mouse <em>Apodemus speciosus </em>but the tick vector remains unknown<em> </em>[<a href="#rid82">82</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>B<em>. crassa</em>-like organisms – These organisms have caused endemic human disease in<em> </em>northeastern China. Isolates are closely related to those found in ticks of the region, including <em>I. persulcatus</em> and <em>Haemaphysalis concinna</em>. They also are closely related to those found in sheep in the same region [<a href="#rid10">10</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>Babesia motasi</em>-like organisms – Two cases have been reported from South Korea. The etiologic agent was initially referred to as K01 [<a href="#rid9">9</a>]. Both isolates are closely related to <em>B. motasi</em>, a species typically found in sheep [<a href="#rid83">83</a>]. <em>Haemaphysalis longicornis</em> is the presumed tick vector.</p><p></p><p class="headingAnchor" id="H19"><span class="h2">Other regions</span><span class="headingEndMark"> — </span>Isolated cases of clinical babesiosis have been reported worldwide, including Australia, Brazil, Canada [<a href="#rid84">84,85</a>], the Canary Islands, Colombia, Egypt, Georgia (in the Caucasus region), India, Mexico, Mozambique, South Africa, and Turkey. Asymptomatic infections have been reported from Bolivia, Brazil, Colombia, Cuba, Mexico, and Mongolia [<a href="#rid9">9,82,86-88</a>].</p><p class="headingAnchor" id="H20"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>The pathogenesis of <em>Babesia</em> species has been studied in animal models (mostly mice, cattle, and dogs) [<a href="#rid89">89</a>]. The release of merozoites from erythrocytes and associated loss of cell membrane integrity cause hemolysis that is associated with many of the clinical manifestations and complications of babesiosis, including fever, anemia, jaundice, hemoglobinuria, and renal insufficiency [<a href="#rid2">2</a>]. The spleen plays a critical role in protection against <em>Babesia</em> infection because it contains macrophages, which ingest and clear infected erythrocytes. (See  <a class="medical medical_review" href="/z/d/html/5670.html" rel="external">"Babesiosis: Clinical manifestations and diagnosis"</a>.)</p><p>Hemolysis contributes to (but does not account entirely for) the anemia associated with babesiosis, which typically is more prolonged than parasitemia. <em>Babesia </em>parasites generate reactive oxygen species; membrane lipid peroxidation decreases red blood cell (RBC) deformability, thereby promoting RBC clearance by splenic macrophages [<a href="#rid90">90</a>]. Opsonization by autologous immunoglobulin G and perhaps complement factors also may contribute to RBC clearance [<a href="#rid90">90,91</a>]. Anemia is coupled with increased erythropoiesis as evidenced by reticulocytosis.</p><p>The role of antibodies in host defense against <em>Babesia </em>is not fully understood. Mouse models of <em>B. microti</em> infection indicate that antibodies are not critical for clearing parasites in immunocompetent hosts because lack of mature B cells in otherwise immunocompetent mice does not alter their resistance to <em>B. microti</em> [<a href="#rid92">92,93</a>]. In immunocompromised patients, however, antibodies appear to be of critical importance because patients treated with <a class="drug drug_general" data-topicid="9616" href="/z/d/drug information/9616.html" rel="external">rituximab</a> (anti-CD20) for B cell lymphoma or an autoimmune disorder are at risk for persistent or relapsing babesiosis. In these patients, resolution of parasitemia often coincides with seroconversion (following cessation of rituximab therapy) [<a href="#rid14">14,94</a>].</p><p>CD4+ T cells are central to host immunity in babesiosis. Babesiosis typically is severe in HIV-infected individuals [<a href="#rid92">92,95,96</a>]. In mice, interferon (IFN)-gamma is critical for host resistance to <em>B. microti</em> and <em>B. duncani</em> [<a href="#rid92">92,95,96</a>]. The main source of IFN-gamma appears to be CD4+ T cells in <em>B. microti</em> infection and NK cells in <em>B. duncani</em> infection. IFN-gamma increases surface expression of MHC class II molecules on antigen-presenting cells and induces or upregulates inflammatory cytokine gene expression.</p><p>Symptoms of babesiosis, such as fever, headache, and myalgia, are similar to viral-like illnesses and are suggestive of a host inflammatory response involving pyrogenic cytokines, such as tumor necrosis factor (TNF)-alpha and interleukin-6. Both cytokines were detected in the blood of a patient with mild babesiosis caused by <em>B. microti</em> [<a href="#rid3">3,86</a>]. Inflammatory cytokines also may contribute to the complications associated with severe babesiosis, such as acute lung injury. In mice infected with <em>B. duncani</em>, pulmonary manifestations include edema and intravascular margination of leukocytes [<a href="#rid97">97</a>]. In these mice, TNF-alpha is localized to the alveolar septa and IFN-gamma around and within pulmonary vessels [<a href="#rid97">97</a>]. Blockade of TNF-alpha prevents death of <em>B. duncani</em>-infected mice, whereas blockade of IFN-gamma promotes death in these mice [<a href="#rid96">96,98</a>].</p><p class="headingAnchor" id="H21"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span>Babesiosis is an emerging infectious disease due to protozoa of the genus <em>Babesia</em> that invade and lyse red blood cells (RBCs). The primary mode of transmission is a tick bite. Rarely, transmission occurs via blood transfusion, solid organ transplantation, or transplacentally. <em>Babesia</em> species are classified in four clades based on their molecular genetic characteristics. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>Babesia microti</em> is the predominant species causing human babesiosis in the United States. Babesiosis due to <em>B. microti</em> is endemic in the northeastern United States (particularly in the coastal counties and on the islands off the coast of southern New England) and in the upper Midwest. (See <a class="local">'United States'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The transmission cycle of <em>B. microti</em> includes ticks, mice, and deer. Adult <em>Ixodes scapularis</em> ticks feed on white-tailed deer, which are not competent reservoirs for <em>B. microti</em> but markedly amplify tick numbers. Tick larvae and nymphs feed on white-footed mice (a major reservoir for <em>B. microti</em>). Nymphs are primary vectors for transmission to humans, who are incidental hosts (<a class="graphic graphic_figure graphicRef65153" href="/z/d/graphic/65153.html" rel="external">figure 2</a>). (See <a class="local">'Transmission'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>Babesia divergens</em> is the principal species causing human babesiosis in Europe. The transmission cycle includes ticks and cattle, and the disease occurs sporadically. (See <a class="local">'Europe'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Babesiosis is increasingly reported from Asia. The major causative species are <em>Babesia venatorum, B. microti</em>,<em> </em>and <em>Babesia crassa</em>-like organism. <em>B. venatorum </em>and <em>B. crassa</em>-like organisms are endemic in northeastern China. <em>B. microti</em> infection has been reported from northeastern and southwestern China. (See <a class="local">'Asia'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A feeding tick introduces sporozoites into the dermis of the vertebrate host. Sporozoites eventually reach the circulation, where they invade RBCs. Within RBCs, sporozoites differentiate into trophozoites, and asexual replication of trophozoites generates two to four merozoites. Egress of merozoites is accompanied by rupture of the host RBCs. Free merozoites in turn invade nearby RBCs. (See <a class="local">'Tick bite'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Anemia and fever are major features of babesiosis. Anemia results, in part, from the hemolysis of RBCs upon egress of merozoites. RBC clearance also may result from decreased deformability and/or from opsonization. Proinflammatory cytokines likely cause fever. (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="headingAnchor" id="H1009558819"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The editorial staff at UpToDate acknowledge Jeffrey A Gelfand, MD, FACP, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Krause PJ, Auwaerter PG, Bannuru RR, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA): 2020 Guideline on Diagnosis and Management of Babesiosis. Clin Infect Dis 2021; 72:185.</a></li><li><a class="nounderline abstract_t">Vannier EG, Diuk-Wasser MA, Ben Mamoun C, Krause PJ. Babesiosis. Infect Dis Clin North Am 2015; 29:357.</a></li><li><a class="nounderline abstract_t">Vannier E, Krause PJ. Human babesiosis. N Engl J Med 2012; 366:2397.</a></li><li><a class="nounderline abstract_t">Sanchez E, Vannier E, Wormser GP, Hu LT. Diagnosis, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: A Review. JAMA 2016; 315:1767.</a></li><li><a class="nounderline abstract_t">Conrad PA, Kjemtrup AM, Carreno RA, et al. Description of Babesia duncani n.sp. (Apicomplexa: Babesiidae) from humans and its differentiation from other piroplasms. Int J Parasitol 2006; 36:779.</a></li><li><a class="nounderline abstract_t">Criado-Fornelio A, Martinez-Marcos A, Buling-Saraña A, Barba-Carretero JC. Molecular studies on Babesia, Theileria and Hepatozoon in southern Europe. Part II. Phylogenetic analysis and evolutionary history. Vet Parasitol 2003; 114:173.</a></li><li><a class="nounderline abstract_t">Goethert HK, Telford SR 3rd. What is Babesia microti? Parasitology 2003; 127:301.</a></li><li><a class="nounderline abstract_t">Nakajima R, Tsuji M, Oda K, et al. Babesia microti-group parasites compared phylogenetically by complete sequencing of the CCTeta gene in 36 isolates. J Vet Med Sci 2009; 71:55.</a></li><li><a class="nounderline abstract_t">Kim JY, Cho SH, Joo HN, et al. First case of human babesiosis in Korea: detection and characterization of a novel type of Babesia sp. (KO1) similar to ovine babesia. J Clin Microbiol 2007; 45:2084.</a></li><li><a class="nounderline abstract_t">Jia N, Zheng YC, Jiang JF, et al. Human Babesiosis Caused by a Babesia crassa-Like Pathogen: A Case Series. Clin Infect Dis 2018; 67:1110.</a></li><li><a class="nounderline abstract_t">Hunfeld KP, Hildebrandt A, Gray JS. Babesiosis: recent insights into an ancient disease. Int J Parasitol 2008; 38:1219.</a></li><li><a class="nounderline abstract_t">Zintl A, Mulcahy G, Skerrett HE, et al. Babesia divergens, a bovine blood parasite of veterinary and zoonotic importance. Clin Microbiol Rev 2003; 16:622.</a></li><li><a class="nounderline abstract_t">Holman PJ. Phylogenetic and biologic evidence that Babesia divergens is not endemic in the United States. Ann N Y Acad Sci 2006; 1081:518.</a></li><li><a class="nounderline abstract_t">Häselbarth K, Tenter AM, Brade V, et al. First case of human babesiosis in Germany - Clinical presentation and molecular characterisation of the pathogen. Int J Med Microbiol 2007; 297:197.</a></li><li><a class="nounderline abstract_t">Telford SR 3rd, Mather TN, Adler GH, Spielman A. Short-tailed shrews as reservoirs of the agents of Lyme disease and human babesiosis. J Parasitol 1990; 76:681.</a></li><li><a class="nounderline abstract_t">Hersh MH, Tibbetts M, Strauss M, et al. Reservoir competence of wildlife host species for Babesia microti. Emerg Infect Dis 2012; 18:1951.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Babesiosis surveillance - 18 States, 2011. MMWR Morb Mortal Wkly Rep 2012; 61:505.</a></li><li><a class="nounderline abstract_t">Stein E, Elbadawi LI, Kazmierczak J, Davis JP. Babesiosis Surveillance - Wisconsin, 2001-2015. MMWR Morb Mortal Wkly Rep 2017; 66:687.</a></li><li><a class="nounderline abstract_t">Joseph JT, John M, Visintainer P, Wormser GP. Increasing incidence and changing epidemiology of babesiosis in the Hudson Valley region of New York State: 2009-2016. Diagn Microbiol Infect Dis 2020; 96:114958.</a></li><li><a class="nounderline abstract_t">Swanson M, Pickrel A, Williamson J, Montgomery S. Trends in Reported Babesiosis Cases - United States, 2011-2019. MMWR Morb Mortal Wkly Rep 2023; 72:273.</a></li><li><a class="nounderline abstract_t">Rosenberg R, Lindsey NP, Fischer M, et al. Vital Signs: Trends in Reported Vectorborne Disease Cases - United States and Territories, 2004-2016. MMWR Morb Mortal Wkly Rep 2018; 67:496.</a></li><li><a class="nounderline abstract_t">Gray EB, Herwaldt BL. Babesiosis Surveillance - United States, 2011-2015. MMWR Surveill Summ 2019; 68:1.</a></li><li><a class="nounderline abstract_t">Ruebush TK 2nd, Juranek DD, Chisholm ES, et al. Human babesiosis on Nantucket Island. Evidence for self-limited and subclinical infections. N Engl J Med 1977; 297:825.</a></li><li><a class="nounderline abstract_t">Krause PJ, McKay K, Gadbaw J, et al. Increasing health burden of human babesiosis in endemic sites. Am J Trop Med Hyg 2003; 68:431.</a></li><li><a class="nounderline abstract_t">Diuk-Wasser MA, Vannier E, Krause PJ. Coinfection by Ixodes Tick-Borne Pathogens: Ecological, Epidemiological, and Clinical Consequences. Trends Parasitol 2016; 32:30.</a></li><li><a class="nounderline abstract_t">Hatcher JC, Greenberg PD, Antique J, Jimenez-Lucho VE. Severe babesiosis in Long Island: review of 34 cases and their complications. Clin Infect Dis 2001; 32:1117.</a></li><li><a class="nounderline abstract_t">White DJ, Talarico J, Chang HG, et al. Human babesiosis in New York State: Review of 139 hospitalized cases and analysis of prognostic factors. Arch Intern Med 1998; 158:2149.</a></li><li><a class="nounderline abstract_t">Herwaldt BL, Linden JV, Bosserman E, et al. Transfusion-associated babesiosis in the United States: a description of cases. Ann Intern Med 2011; 155:509.</a></li><li><a class="nounderline abstract_t">Gubernot DM, Lucey CT, Lee KC, et al. Babesia infection through blood transfusions: reports received by the US Food and Drug Administration, 1997-2007. Clin Infect Dis 2009; 48:25.</a></li><li><a class="nounderline abstract_t">Leiby DA. Transfusion-transmitted Babesia spp.: bull's-eye on Babesia microti. Clin Microbiol Rev 2011; 24:14.</a></li><li><a class="nounderline abstract_t">Bloch EM, Krause PJ, Tonnetti L. Preventing Transfusion-Transmitted Babesiosis. Pathogens 2021; 10.</a></li><li><a class="nounderline abstract_t">Johnson ST, Cable RG, Leiby DA. Lookback investigations of Babesia microti-seropositive blood donors: seven-year experience in a Babesia-endemic area. Transfusion 2012; 52:1509.</a></li><li class="breakAll">US Food and Drug Administration. Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/recommendations-reducing-risk-transfusion-transmitted-babesiosis (Accessed on May 13, 2021).</li><li><a class="nounderline abstract_t">Lobo CA, Singh M, Rodriguez M. Human babesiosis: recent advances and future challenges. Curr Opin Hematol 2020; 27:399.</a></li><li><a class="nounderline abstract_t">Bloch EM, Krause PJ. Blood Screening for Babesia in the blood supply. Annals of Blood 2020.</a></li><li><a class="nounderline abstract_t">Tonnetti L, Young C, Kessler DA, et al. Transcription-mediated amplification blood donation screening for Babesia. Transfusion 2020; 60:317.</a></li><li><a class="nounderline abstract_t">Stanley J, Stramer SL, Erickson Y, et al. Detection of Babesia RNA and DNA in whole blood samples from US blood donations. Transfusion 2021; 61:2969.</a></li><li><a class="nounderline abstract_t">Tonnetti L, Dodd RY, Foster G, Stramer SL. Babesia blood testing: the first-year experience. Transfusion 2022; 62:135.</a></li><li><a class="nounderline abstract_t">Brennan MB, Herwaldt BL, Kazmierczak JJ, et al. Transmission of Babesia microti Parasites by Solid Organ Transplantation. Emerg Infect Dis 2016; 22.</a></li><li><a class="nounderline abstract_t">Joseph JT, Purtill K, Wong SJ, et al. Vertical transmission of Babesia microti, United States. Emerg Infect Dis 2012; 18:1318.</a></li><li><a class="nounderline abstract_t">Cornett JK, Malhotra A, Hart D. Vertical transmission of babesiosis from a pregnant, splenectomized mother to her neonate. Infect Dis Clin Pract 2012; 20:408.</a></li><li><a class="nounderline abstract_t">Yager PH, Luginbuhl LM, Dekker JP. Case records of the Massachusetts General Hospital. Case 6-2014. A 35-day-old boy with fever, vomiting, mottled skin, and severe anemia. N Engl J Med 2014; 370:753.</a></li><li><a class="nounderline abstract_t">Surra ND, Jesus JE. The anemic and thrombocytopenic febrile neonate. J Emerg Med 2015; 48:675.</a></li><li><a class="nounderline abstract_t">Saetre K, Godhwani N, Maria M, et al. Congenital Babesiosis After Maternal Infection With Borrelia burgdorferi and Babesia microti. J Pediatric Infect Dis Soc 2018; 7:e1.</a></li><li><a class="nounderline abstract_t">Fox LM, Wingerter S, Ahmed A, et al. Neonatal babesiosis: case report and review of the literature. Pediatr Infect Dis J 2006; 25:169.</a></li><li><a class="nounderline abstract_t">Sethi S, Alcid D, Kesarwala H, Tolan RW Jr. Probable congenital babesiosis in infant, new jersey, USA. Emerg Infect Dis 2009; 15:788.</a></li><li><a class="nounderline abstract_t">Aderinboye O, Syed SS. Congenital babesiosis in a four-week-old female infant. Pediatr Infect Dis J 2010; 29:188.</a></li><li><a class="nounderline abstract_t">Vannier E, Krause PJ. Transplacental transmission of human babesiosis. Infect Dis Clin Pract (Baltim Md) 2012; 20:365.</a></li><li><a class="nounderline abstract_t">Taiwo B, Lee C, Venkat D, et al. Can tumor necrosis factor alpha blockade predispose to severe babesiosis? Arthritis Rheum 2007; 57:179.</a></li><li><a class="nounderline abstract_t">Cullen G, Sands BE, Yajnik V. Babesiosis in a patient on infliximab for Crohn's disease. Inflamm Bowel Dis 2010; 16:1269.</a></li><li><a class="nounderline abstract_t">Bogoch II, Davis BT, Hooper DC. Severe babesiosis in a patient treated with a tumor necrosis factor α antagonist. Clin Infect Dis 2012; 54:1215.</a></li><li><a class="nounderline abstract_t">Mareedu N, Schotthoefer AM, Tompkins J, et al. Risk Factors for Severe Infection, Hospitalization, and Prolonged Antimicrobial Therapy in Patients with Babesiosis. Am J Trop Med Hyg 2017; 97:1218.</a></li><li><a class="nounderline abstract_t">Krause PJ, Telford SR 3rd, Spielman A, et al. Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness. JAMA 1996; 275:1657.</a></li><li><a class="nounderline abstract_t">Swei A, O'Connor KE, Couper LI, et al. Evidence for transmission of the zoonotic apicomplexan parasite Babesia duncani by the tick Dermacentor albipictus. Int J Parasitol 2019; 49:95.</a></li><li><a class="nounderline abstract_t">Herwaldt BL, Kjemtrup AM, Conrad PA, et al. Transfusion-transmitted babesiosis in Washington State: first reported case caused by a WA1-type parasite. J Infect Dis 1997; 175:1259.</a></li><li><a class="nounderline abstract_t">Quick RE, Herwaldt BL, Thomford JW, et al. Babesiosis in Washington State: a new species of Babesia? Ann Intern Med 1993; 119:284.</a></li><li><a class="nounderline abstract_t">Kjemtrup AM, Lee B, Fritz CL, et al. Investigation of transfusion transmission of a WA1-type babesial parasite to a premature infant in California. Transfusion 2002; 42:1482.</a></li><li><a class="nounderline abstract_t">Persing DH, Herwaldt BL, Glaser C, et al. Infection with a babesia-like organism in northern California. N Engl J Med 1995; 332:298.</a></li><li><a class="nounderline abstract_t">Bloch EM, Herwaldt BL, Leiby DA, et al. The third described case of transfusion-transmitted Babesia duncani. Transfusion 2012; 52:1517.</a></li><li><a class="nounderline abstract_t">Herwaldt B, Persing DH, Précigout EA, et al. A fatal case of babesiosis in Missouri: identification of another piroplasm that infects humans. Ann Intern Med 1996; 124:643.</a></li><li><a class="nounderline abstract_t">Beattie JF, Michelson ML, Holman PJ. Acute babesiosis caused by Babesia divergens in a resident of Kentucky. N Engl J Med 2002; 347:697.</a></li><li><a class="nounderline abstract_t">Herwaldt BL, de Bruyn G, Pieniazek NJ, et al. Babesia divergens-like infection, Washington State. Emerg Infect Dis 2004; 10:622.</a></li><li><a class="nounderline abstract_t">Burgess MJ, Rosenbaum ER, Pritt BS, et al. Possible Transfusion-Transmitted Babesia divergens-like/MO-1 Infection in an Arkansas Patient. Clin Infect Dis 2017; 64:1622.</a></li><li><a class="nounderline abstract_t">Hunfeld KP, Lambert A, Kampen H, et al. Seroprevalence of Babesia infections in humans exposed to ticks in midwestern Germany. J Clin Microbiol 2002; 40:2431.</a></li><li><a class="nounderline abstract_t">Sonnleitner ST, Fritz J, Bednarska M, et al. Risk assessment of transfusion-associated babesiosis in Tyrol: appraisal by seroepidemiology and polymerase chain reaction. Transfusion 2014; 54:1725.</a></li><li><a class="nounderline abstract_t">Uhnoo I, Cars O, Christensson D, Nyström-Rosander C. First documented case of human babesiosis in Sweden. Scand J Infect Dis 1992; 24:541.</a></li><li><a class="nounderline abstract_t">Hildebrandt A, Hunfeld KP, Baier M, et al. First confirmed autochthonous case of human Babesia microti infection in Europe. Eur J Clin Microbiol Infect Dis 2007; 26:595.</a></li><li><a class="nounderline abstract_t">Welc-Falęciak R, Pawełczyk A, Radkowski M, et al. First report of two asymptomatic cases of human infection with Babesia microti (Franca, 1910) in Poland. Ann Agric Environ Med 2015; 22:51.</a></li><li><a class="nounderline abstract_t">Foppa IM, Krause PJ, Spielman A, et al. Entomologic and serologic evidence of zoonotic transmission of Babesia microti, eastern Switzerland. Emerg Infect Dis 2002; 8:722.</a></li><li><a class="nounderline abstract_t">Genchi C. Human babesiosis, an emerging zoonosis. Parassitologia 2007; 49 Suppl 1:29.</a></li><li><a class="nounderline abstract_t">Lempereur L, Shiels B, Heyman P, et al. A retrospective serological survey on human babesiosis in Belgium. Clin Microbiol Infect 2015; 21:96.e1.</a></li><li><a class="nounderline abstract_t">Herwaldt BL, Cacciò S, Gherlinzoni F, et al. Molecular characterization of a non-Babesia divergens organism causing zoonotic babesiosis in Europe. Emerg Infect Dis 2003; 9:942.</a></li><li><a class="nounderline abstract_t">Bonnet S, Jouglin M, L'Hostis M, Chauvin A. Babesia sp. EU1 from roe deer and transmission within Ixodes ricinus. Emerg Infect Dis 2007; 13:1208.</a></li><li><a class="nounderline abstract_t">Blum S, Gattringer R, Haschke E, et al. The case: hemolysis and acute renal failure. Babesiosis. Kidney Int 2011; 80:681.</a></li><li><a class="nounderline abstract_t">Bläckberg J, Lazarevic VL, Hunfeld KP, Persson KEM. Low-virulent Babesia venatorum infection masquerading as hemophagocytic syndrome. Ann Hematol 2018; 97:731.</a></li><li><a class="nounderline abstract_t">Jiang JF, Zheng YC, Jiang RR, et al. Epidemiological, clinical, and laboratory characteristics of 48 cases of "Babesia venatorum" infection in China: a descriptive study. Lancet Infect Dis 2015; 15:196.</a></li><li><a class="nounderline abstract_t">Fang LQ, Liu K, Li XL, et al. Emerging tick-borne infections in mainland China: an increasing public health threat. Lancet Infect Dis 2015; 15:1467.</a></li><li><a class="nounderline abstract_t">Zhou X, Xia S, Huang JL, et al. Human babesiosis, an emerging tick-borne disease in the People's Republic of China. Parasit Vectors 2014; 7:509.</a></li><li><a class="nounderline abstract_t">Man SQ, Qiao K, Cui J, et al. A case of human infection with a novel Babesia species in China. Infect Dis Poverty 2016; 5:28.</a></li><li><a class="nounderline abstract_t">Bloch EM, Yang Y, He M, et al. A pilot serosurvey of Babesia microti in Chinese blood donors. Vox Sang 2018; 113:345.</a></li><li><a class="nounderline abstract_t">Zhou X, Xia S, Yin SQ, Zhou XN. Emergence of babesiosis in China-Myanmar border areas. Parasit Vectors 2015; 8:390.</a></li><li><a class="nounderline abstract_t">Wei Q, Tsuji M, Zamoto A, et al. Human babesiosis in Japan: isolation of Babesia microti-like parasites from an asymptomatic transfusion donor and from a rodent from an area where babesiosis is endemic. J Clin Microbiol 2001; 39:2178.</a></li><li><a class="nounderline abstract_t">Hong SH, Kim SY, Song BG, et al. Detection and characterization of an emerging type of Babesia sp. similar to Babesia motasi for the first case of human babesiosis and ticks in Korea. Emerg Microbes Infect 2019; 8:869.</a></li><li><a class="nounderline abstract_t">Bullard JM, Ahsanuddin AN, Perry AM, et al. The first case of locally acquired tick-borne Babesia microti infection in Canada. Can J Infect Dis Med Microbiol 2014; 25:e87.</a></li><li><a class="nounderline abstract_t">Yang J, Smith C, Battad A. Babesia microti acquired in Canada. CMAJ 2021; 193:E1213.</a></li><li><a class="nounderline abstract_t">Shaio MF, Lin PR. A case study of cytokine profiles in acute human babesiosis. Am J Trop Med Hyg 1998; 58:335.</a></li><li><a class="nounderline abstract_t">Shih CM, Liu LP, Chung WC, et al. Human babesiosis in Taiwan: asymptomatic infection with a Babesia microti-like organism in a Taiwanese woman. J Clin Microbiol 1997; 35:450.</a></li><li><a class="nounderline abstract_t">Senanayake SN, Paparini A, Latimer M, et al. First report of human babesiosis in Australia. Med J Aust 2012; 196:350.</a></li><li><a class="nounderline abstract_t">Krause PJ, Daily J, Telford SR, et al. Shared features in the pathobiology of babesiosis and malaria. Trends Parasitol 2007; 23:605.</a></li><li><a class="nounderline abstract_t">Otsuka Y, Yamasaki M, Yamato O, Maede Y. Increased generation of superoxide in erythrocytes infected with Babesia gibsoni. J Vet Med Sci 2001; 63:1077.</a></li><li><a class="nounderline abstract_t">Woolley AE, Montgomery MW, Savage WJ, et al. Post-Babesiosis Warm Autoimmune Hemolytic Anemia. N Engl J Med 2017; 376:939.</a></li><li><a class="nounderline abstract_t">Clawson ML, Paciorkowski N, Rajan TV, et al. Cellular immunity, but not gamma interferon, is essential for resolution of Babesia microti infection in BALB/c mice. Infect Immun 2002; 70:5304.</a></li><li><a class="nounderline abstract_t">Cavacini LA, Parke LA, Weidanz WP. Resolution of acute malarial infections by T cell-dependent non-antibody-mediated mechanisms of immunity. Infect Immun 1990; 58:2946.</a></li><li><a class="nounderline abstract_t">Krause PJ, Gewurz BE, Hill D, et al. Persistent and relapsing babesiosis in immunocompromised patients. Clin Infect Dis 2008; 46:370.</a></li><li><a class="nounderline abstract_t">Igarashi I, Waki S, Ito M, et al. Role of CD4+ T cells in the control of primary infection with Babesia microti in mice. J Protozool Res 1994; 4:164.</a></li><li><a class="nounderline abstract_t">Aguilar-Delfin I, Wettstein PJ, Persing DH. Resistance to acute babesiosis is associated with interleukin-12- and gamma interferon-mediated responses and requires macrophages and natural killer cells. Infect Immun 2003; 71:2002.</a></li><li><a class="nounderline abstract_t">Hemmer RM, Ferrick DA, Conrad PA. Up-regulation of tumor necrosis factor-alpha and interferon-gamma expression in the spleen and lungs of mice infected with the human Babesia isolate WA1. Parasitol Res 2000; 86:121.</a></li><li><a class="nounderline abstract_t">Hemmer RM, Ferrick DA, Conrad PA. Role of T cells and cytokines in fatal and resolving experimental babesiosis: protection in TNFRp55-/- mice infected with the human Babesia WA1 parasite. J Parasitol 2000; 86:736.</a></li></ol></div><div id="topicVersionRevision">Topic 5734 Version 34.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33501959" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA): 2020 Guideline on Diagnosis and Management of Babesiosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25999229" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Babesiosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22716978" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Human babesiosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27115378" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Diagnosis, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: A Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16725142" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Description of Babesia duncani n.sp. (Apicomplexa: Babesiidae) from humans and its differentiation from other piroplasms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12788253" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Molecular studies on Babesia, Theileria and Hepatozoon in southern Europe. Part II. Phylogenetic analysis and evolutionary history.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14636016" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : What is Babesia microti?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19194077" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Babesia microti-group parasites compared phylogenetically by complete sequencing of the CCTeta gene in 36 isolates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17392446" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : First case of human babesiosis in Korea: detection and characterization of a novel type of Babesia sp. (KO1) similar to ovine babesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29538646" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Human Babesiosis Caused by a Babesia crassa-Like Pathogen: A Case Series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18440005" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Babesiosis: recent insights into an ancient disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14557289" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Babesia divergens, a bovine blood parasite of veterinary and zoonotic importance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17135561" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Phylogenetic and biologic evidence that Babesia divergens is not endemic in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17350888" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : First case of human babesiosis in Germany - Clinical presentation and molecular characterisation of the pathogen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2213411" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Short-tailed shrews as reservoirs of the agents of Lyme disease and human babesiosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23171673" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Reservoir competence of wildlife host species for Babesia microti.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22785341" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Babesiosis surveillance - 18 States, 2011.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28683059" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Babesiosis Surveillance - Wisconsin, 2001-2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31813641" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Increasing incidence and changing epidemiology of babesiosis in the Hudson Valley region of New York State: 2009-2016.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36928071" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Trends in Reported Babesiosis Cases - United States, 2011-2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29723166" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Vital Signs: Trends in Reported Vectorborne Disease Cases - United States and Territories, 2004-2016.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31145719" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Babesiosis Surveillance - United States, 2011-2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/561308" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Human babesiosis on Nantucket Island. Evidence for self-limited and subclinical infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12875292" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Increasing health burden of human babesiosis in endemic sites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26613664" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Coinfection by Ixodes Tick-Borne Pathogens: Ecological, Epidemiological, and Clinical Consequences.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11283800" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Severe babesiosis in Long Island: review of 34 cases and their complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9801183" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Human babesiosis in New York State: Review of 139 hospitalized cases and analysis of prognostic factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21893613" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Transfusion-associated babesiosis in the United States: a description of cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19035776" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Babesia infection through blood transfusions: reports received by the US Food and Drug Administration, 1997-2007.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21233506" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Transfusion-transmitted Babesia spp.: bull's-eye on Babesia microti.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34578209" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Preventing Transfusion-Transmitted Babesiosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21910741" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Lookback investigations of Babesia microti-seropositive blood donors: seven-year experience in a Babesia-endemic area.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21910741" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Lookback investigations of Babesia microti-seropositive blood donors: seven-year experience in a Babesia-endemic area.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32889826" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Human babesiosis: recent advances and future challenges.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Blood Screening for Babesia in the blood supply.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31885102" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Transcription-mediated amplification blood donation screening for Babesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34368968" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Detection of Babesia RNA and DNA in whole blood samples from US blood donations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34726279" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Babesia blood testing: the first-year experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27767010" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Transmission of Babesia microti Parasites by Solid Organ Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22840424" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Vertical transmission of Babesia microti, United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Vertical transmission of babesiosis from a pregnant, splenectomized mother to her neonate</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24552323" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Case records of the Massachusetts General Hospital. Case 6-2014. A 35-day-old boy with fever, vomiting, mottled skin, and severe anemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25895861" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : The anemic and thrombocytopenic febrile neonate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28992325" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Congenital Babesiosis After Maternal Infection With Borrelia burgdorferi and Babesia microti.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16462298" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Neonatal babesiosis: case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19402971" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Probable congenital babesiosis in infant, new jersey, USA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20118748" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Congenital babesiosis in a four-week-old female infant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Transplacental transmission of human babesiosis</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17266091" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Can tumor necrosis factor alpha blockade predispose to severe babesiosis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19885904" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Babesiosis in a patient on infliximab for Crohn's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22354920" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Severe babesiosis in a patient treated with a tumor necrosis factorαantagonist.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28722598" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Risk Factors for Severe Infection, Hospitalization, and Prolonged Antimicrobial Therapy in Patients with Babesiosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8637139" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30367862" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Evidence for transmission of the zoonotic apicomplexan parasite Babesia duncani by the tick Dermacentor albipictus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9129100" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Transfusion-transmitted babesiosis in Washington State: first reported case caused by a WA1-type parasite.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8328736" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Babesiosis in Washington State: a new species of Babesia?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12421222" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Investigation of transfusion transmission of a WA1-type babesial parasite to a premature infant in California.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7816065" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Infection with a babesia-like organism in northern California.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22168221" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : The third described case of transfusion-transmitted Babesia duncani.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8607592" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : A fatal case of babesiosis in Missouri: identification of another piroplasm that infects humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12200568" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Acute babesiosis caused by Babesia divergens in a resident of Kentucky.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15200851" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Babesia divergens-like infection, Washington State.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28329282" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Possible Transfusion-Transmitted Babesia divergens-like/MO-1 Infection in an Arkansas Patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12089258" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Seroprevalence of Babesia infections in humans exposed to ticks in midwestern Germany.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24673158" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Risk assessment of transfusion-associated babesiosis in Tyrol: appraisal by seroepidemiology and polymerase chain reaction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1411322" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : First documented case of human babesiosis in Sweden.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17587072" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : First confirmed autochthonous case of human Babesia microti infection in Europe.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25780828" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : First report of two asymptomatic cases of human infection with Babesia microti (Franca, 1910) in Poland.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12095442" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Entomologic and serologic evidence of zoonotic transmission of Babesia microti, eastern Switzerland.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17691604" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Human babesiosis, an emerging zoonosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25636942" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : A retrospective serological survey on human babesiosis in Belgium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12967491" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Molecular characterization of a non-Babesia divergens organism causing zoonotic babesiosis in Europe.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17953093" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Babesia sp. EU1 from roe deer and transmission within Ixodes ricinus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21878956" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : The case: hemolysis and acute renal failure. Babesiosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29285582" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Low-virulent Babesia venatorum infection masquerading as hemophagocytic syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25539588" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Epidemiological, clinical, and laboratory characteristics of 48 cases of "Babesia venatorum" infection in China: a descriptive study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26453241" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Emerging tick-borne infections in mainland China: an increasing public health threat.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25403908" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Human babesiosis, an emerging tick-borne disease in the People's Republic of China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27025290" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : A case of human infection with a novel Babesia species in China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29582438" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : A pilot serosurvey of Babesia microti in Chinese blood donors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26204984" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Emergence of babesiosis in China-Myanmar border areas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11376054" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Human babesiosis in Japan: isolation of Babesia microti-like parasites from an asymptomatic transfusion donor and from a rodent from an area where babesiosis is endemic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31179860" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Detection and characterization of an emerging type of Babesia sp. similar to Babesia motasi for the first case of human babesiosis and ticks in Korea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25587297" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : The first case of locally acquired tick-borne Babesia microti infection in Canada.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34373269" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Babesia microti acquired in Canada.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9546414" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : A case study of cytokine profiles in acute human babesiosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9003614" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Human babesiosis in Taiwan: asymptomatic infection with a Babesia microti-like organism in a Taiwanese woman.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22432676" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : First report of human babesiosis in Australia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17988944" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Shared features in the pathobiology of babesiosis and malaria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11714022" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Increased generation of superoxide in erythrocytes infected with Babesia gibsoni.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28273010" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Post-Babesiosis Warm Autoimmune Hemolytic Anemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12183588" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Cellular immunity, but not gamma interferon, is essential for resolution of Babesia microti infection in BALB/c mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2387628" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Resolution of acute malarial infections by T cell-dependent non-antibody-mediated mechanisms of immunity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18181735" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Persistent and relapsing babesiosis in immunocompromised patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Role of CD4+ T cells in the control of primary infection with Babesia microti in mice</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12654819" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Resistance to acute babesiosis is associated with interleukin-12- and gamma interferon-mediated responses and requires macrophages and natural killer cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10685843" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Up-regulation of tumor necrosis factor-alpha and interferon-gamma expression in the spleen and lungs of mice infected with the human Babesia isolate WA1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10958449" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Role of T cells and cytokines in fatal and resolving experimental babesiosis: protection in TNFRp55-/- mice infected with the human Babesia WA1 parasite.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
